Avenacy

Generic Drugs
1hiring now · open roles
$26Mlatest round · Venture round · Nov 2024 · 23 mo ago
50+team · employees, estimated range
2023founded

Overview

Avenacy is focused on supplying critical medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices.

Funding and backers

Total raised
$26M
1 round on record
Latest round
$26M
Venture round · Nov 2024 · 23 mo ago
Team
51-200
employees, estimated range
Hiring now
1
open roles
The money's age
Due for its next round
23 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 15, 2024 Raised a round Venture round $26M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Nov 2024 $26M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Avenacy Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jeffrey YordonExecutive Officer, DirectorSEC Form D
Kam PhulwaniExecutive Officer, DirectorSEC Form D
Joe MaseExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Kaigo Health
Antler
backs Synthax
Entrepreneur First
backs Miisttherapeutics
Union Square Ventures
backs QbD RepS UK Ltd
RA Capital Management
backs NexCure
Fuel Ventures
backs Synthax
Similar startupsby what they do, their industry and backers
Kaigo Health
Super-powered business office for post-acute care.
aiomicsFounded 2025 · 201-500 employees
Medical letter drafts, referrals and admissions, payer enquiries and digital patient questionnaires. aiomics supports rehabilitation and…
PlatinumRx7 roles
Buy FDA & GMP certified generic medicines online at PlatinumRx. Save up to 60% with pan-India delivery. Trusted by 10L+ customers for 100%…
Introducing Keenova and Par HealthVenture round $170.6M · 2 yr ago · Founded 2023 · 201-500 employees
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Stay tuned for updates.
QbD RepS UK Ltd11-50 employees
Alife is building technology for both clinics and patients.
Miisttherapeutics
Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours.

Growth

Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 days
11/07/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Management
100% ▼

Financials

Total raised
$26M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $26M Details

People

Jeffrey Yordon
Executive Officer, Director
SEC Form D
Kam Phulwani
Executive Officer, Director
SEC Form D
Joe Mase
Executive Officer
SEC Form D
Patrick Soon-Shiong
Director
SEC Form D
Douglas Maughan
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Tech stack

The technologies known for Avenacy, by layer.
Developer tools
Microsoft Excel
Sign in to see how your skills match this stack Sign In

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Schaumburg
Schaumburg United States
HQ
Avenacy
1 open roles 100% remote 50-200 est. staff
hires for Management
10 N. Martingale Road, Suite 225, Schaumburg, IL 60173
seen since Sep 2025 company site, job postings